Literature DB >> 31878859

Preliminary Anti-Coxsackie Activity of Novel 1-[4-(5,6-dimethyl(H)- 1H(2H)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas.

Sandra Piras1, Paola Corona1, Roberta Ibba1, Federico Riu1, Gabriele Murineddu1, Giuseppina Sanna2, Silvia Madeddu2, Ilenia Delogu2, Roberta Loddo2, Antonio Carta1.   

Abstract

BACKGROUND: Coxsackievirus infections are associated with cases of aseptic meningitis, encephalitis, myocarditis, and some chronic disease.
METHODS: A series of benzo[d][1,2,3]triazol-1(2)-yl derivatives (here named benzotriazol-1(2)-yl) (4a-i, 5a-h, 6a-e, g, i, j and 7a-f, h-j) were designed, synthesized and in vitro evaluated for cytotoxicity and antiviral activity against two important human enteroviruses (HEVs) members of the Picornaviridae family [Coxsackievirus B 5 (CVB-5) and Poliovirus 1 (Sb-1)].
RESULTS: Compounds 4c (CC50 >100 μM; EC50 = 9 μM), 5g (CC50 >100 μM; EC50 = 8 μM), and 6a (CC50 >100 μM; EC50 = 10 μM) were found active against CVB-5. With the aim of evaluating the selectivity of action of this class of compounds, a wide spectrum of RNA (positive- and negativesense), double-stranded (dsRNA) or DNA viruses were also assayed. For none of them, significant antiviral activity was determined.
CONCLUSION: These results point towards a selective activity against CVB-5, an important human pathogen that causes both acute and chronic diseases in infants, young children, and immunocompromised patients. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Benzotriazole derivatives; antiviral activity; coxsackievirus; cytotoxicity; enterovirus; picornaviridae; rna virus

Mesh:

Substances:

Year:  2020        PMID: 31878859     DOI: 10.2174/1573406416666191226142744

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  3 in total

1.  Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative.

Authors:  Roberta Ibba; Antonio Carta; Silvia Madeddu; Paola Caria; Gabriele Serreli; Sandra Piras; Simona Sestito; Roberta Loddo; Giuseppina Sanna
Journal:  Viruses       Date:  2021-01-04       Impact factor: 5.048

2.  Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets.

Authors:  Silvia Madeddu; Roberta Ibba; Giuseppina Sanna; Sandra Piras; Federico Riu; Alessandra Marongiu; Annalisa Ambrosino; Paola Caria; Valentina Onnis; Gianluigi Franci; Aldo Manzin; Antonio Carta
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-31

3.  5,6-Dichloro-2-phenyl-benzotriazoles: New Potent Inhibitors of Orthohantavirus.

Authors:  Giuseppina Sanna; Sandra Piras; Silvia Madeddu; Bernardetta Busonera; Boris Klempa; Paola Corona; Roberta Ibba; Gabriele Murineddu; Antonio Carta; Roberta Loddo
Journal:  Viruses       Date:  2020-01-20       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.